NCT02708901View on ClinicalTrials.gov

Gut to Brain Interaction in Autism. Role of Probiotics on Clinical, Biochemical and Neurophysiological Parameters

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

September 30, 2018

Conditions
Autism Spectrum Disorder
Interventions
DIETARY_SUPPLEMENT

Vivomixx®

Two packets (900 billions bacteria) per os (P.O.) daily x 1 month and one packet (450 billions bacteria) P.O. daily x 5 months

DIETARY_SUPPLEMENT

Placebo

Two packets (4,4 grams of maltose and silicon dioxide x 2) P.O. daily x 1 month and one packet (4,4 grams of maltose and silicon dioxide) P.O. daily x 5 months

Trial Locations (1)

56128

IRCCS Stella Maris Foundation, Calambrone

All Listed Sponsors
collaborator

Ministry of Health, Italy

OTHER_GOV

collaborator

Istituto di Fisiologia Clinica CNR

OTHER

lead

IRCCS Fondazione Stella Maris

OTHER

NCT02708901 - Gut to Brain Interaction in Autism. Role of Probiotics on Clinical, Biochemical and Neurophysiological Parameters | Biotech Hunter | Biotech Hunter